(MGCD) (MGCD) Stock Price, News & Analysis

Company Overview

MGC Diagnostics Corporation is a medical technology company, which offers cardiorespiratory health solutions. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products. It sells its products internationally through distributors and in the United States through a direct sales force targeting specialists located in hospitals, university-based medical centers, medical clinics, physician offices, pharmaceutical companies, medical device manufacturers and clinical research organizations (CROs). Its cardiorespiratory diagnostic products measure flow and respiratory pressures and, in most cases analyze the inhaled and exhaled gases, such as oxygen and carbon dioxide. Its products include pulmonary function (PFT) and gas exchange (GX) testing products. The Company's pulmonary function products are divided into four product categories: Spirometry, Complete Pulmonary Function, Body Plethysmography and Specialty Products.

Key Stats

• Today's Range: $11.03 to $11.03
• 50-Day Range: N/A
• 52-Week Range: $6.24 to $11.20
• Volume: N/A
• Average Volume: 15,965 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MGCD Stock Analysis - Frequently Asked Questions

How were (MGCD)'s earnings last quarter?

(MGCD) (NASDAQ:MGCD) announced its quarterly earnings data on Wednesday, September, 7th. The medical equipment provider reported $0.06 earnings per share for the quarter. The medical equipment provider had revenue of $9.90 million for the quarter, compared to analyst estimates of $9.20 million.

What other stocks do shareholders of (MGCD) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that (MGCD) investors own include Allena Pharmaceuticals (ALNA), Akers Biosciences (AKER), Ampliphi Biosciences (APHB), Veru (VERU), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF) and Achieve Life Sciences (ACHV).

Company Calendar

• Last Earnings: 9/07/2016
• Today: 6/26/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:MGCD
• Previous Symbol: NASDAQ:ANGN
• CIK: 815093
• Web: mgcdiagnostics.com
• Phone: +1-651-4844874
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A